DarioHealth
DRIO | NASDAQ
$1.15
-$0.11 (-8.73%)
At close: Nov 16, 2026, 4:00 PM ET
$1.20
+$0.05 (+4.35%)
After-hours:
Nov 16, 2026, 7:13 PM ET
-8.73%
(1D)No price chart data available for 1D timeframe.
Rating
50
+1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #285/1021 (Top 28%)
Key Statistics
Market Data
Market Cap $13.87M
1D Range
1.09 1.47
52W Range
1.09 14.00
Valuation (TTM)
PE 7.67
PB 0.19
EV/EBITDA -0.54
Valuation (NTM)
Forward PE N/A
Forward PEG -0.12
Price Target $6.00
Cash Flow
FCF Yield -166.3%
SBC Adj. FCF Yield -211.8%
SBC Impact -27.4%
Margins
Gross Margin 55.9%
Operating Margin -317.4%
FCF Margin -108.3%
Growth (CAGR)
Revenue 3Y | 5Y -3.3% |
5.2%
Dil EPS 3Y | 5Y 94.4% |
58.5%
FCF 3Y | 5Y 27.4% |
19.8%
Returns
ROA 54.3%
ROE 95.1%
ROIC -64.5%
Financial Health
Net Debt
$94K
Current Ratio 4.20
Interest Coverage -12.30
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health soluti...
Sector Healthcare
Industry Medical - Specialties
Employees 163
IPO Date Mar 14, 2016
Website www.dariohealth.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.73
Beat +23.16%
YoY:
+60.54% REV
$5.31M
Beat +1.97%
YoY:
+6.07%Next Earnings
Mar 18, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
2
Consensus
Hold
Price Target
$6.00
Upside
+421.74%
Buy (1)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove DRIO